Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Increased serum folate levels associated with reduced breast cancer risk
August 6th, 2004
Increased serum folate levels are associated with reduced breast cancer risk. "Breast cancer risk may be associated with folate status or the C677T genotype of the methylenetetrahydrofolate reductase (MTHFR) gene. We compared serum folate concentrations and C677T genotype in 141 breast cancer patients and 109 age-matched controls," scientists in Australia report. "Serum folate was significantly lower in cases compared to controls (geometric means, 5.7 vs. 6.6 mcg/L; p=.005). Breast cancer risk was not associated with C677T genotype," wrote J. Beilby and coauthors. "After adjusting for age of menarche, parity, alcohol intake and...
Source: Genomics & Genetics Weekly (2004-08-06)
|
